Literature DB >> 10465141

Ketogenic diet in the treatment of refractory epilepsy in childhood.

A M Hassan1, D L Keene, S E Whiting, P J Jacob, J R Champagne, P Humphreys.   

Abstract

There has been renewed interest in the ketogenic diet in the treatment of medically refractory seizure disorders in childhood. This article reports the results of a retrospective chart review of 52 patients who were treated with the ketogenic diet. The vast majority (49 of 52) were treated with the classic 4:1 diet. Seizure control improved in 67.3% of patients with complete abolition of seizures in six. Adverse reactions were uncommon and included the development of renal stones, gall bladder stones, and hypoproteinemia in one patient each. Routine biochemical screening during the diet did not identify or prevent adverse events. The authors' experiences with the diet emphasize the need for close ongoing medical and dietary supervision.

Entities:  

Mesh:

Year:  1999        PMID: 10465141     DOI: 10.1016/s0887-8994(99)00045-4

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  21 in total

1.  Food for thought: the ketogenic diet and adverse effects in children.

Authors:  Michael S Duchowny
Journal:  Epilepsy Curr       Date:  2005 Jul-Aug       Impact factor: 7.500

Review 2.  A risk-benefit assessment of treatments for infantile spasms.

Authors:  R Nabbout
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  Adenosine and autism: a spectrum of opportunities.

Authors:  Susan A Masino; Masahito Kawamura; Jessica L Cote; Rebecca B Williams; David N Ruskin
Journal:  Neuropharmacology       Date:  2012-08-24       Impact factor: 5.250

Review 4.  Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.

Authors:  Detlev Boison; Jong M Rho
Journal:  Neuropharmacology       Date:  2019-08-13       Impact factor: 5.250

5.  Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy.

Authors:  Elahna Paul; Kerry D Conant; Irie E Dunne; Heidi H Pfeifer; David A Lyczkowski; Michael A Linshaw; Elizabeth A Thiele
Journal:  Epilepsy Res       Date:  2010-05-13       Impact factor: 3.045

Review 6.  Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease.

Authors:  Raja Gopal Reddy Mooli; Sadeesh K Ramakrishnan
Journal:  Front Physiol       Date:  2022-07-04       Impact factor: 4.755

Review 7.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

Review 8.  Ketogenic diet, neuroprotection, and antiepileptogenesis.

Authors:  Madhuvika Murugan; Detlev Boison
Journal:  Epilepsy Res       Date:  2020-08-19       Impact factor: 3.045

9.  M-Channel Activation Contributes to the Anticonvulsant Action of the Ketone Body β-Hydroxybutyrate.

Authors:  Rían W Manville; Maria Papanikolaou; Geoffrey W Abbott
Journal:  J Pharmacol Exp Ther       Date:  2019-11-22       Impact factor: 4.030

Review 10.  Ketogenic diets: evidence for short- and long-term efficacy.

Authors:  Eric H Kossoff; Jong M Rho
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.